Literature DB >> 7311396

Effect of pentoxifylline on single red cell deformability.

D Seiffge, H Kiesewetter.   

Abstract

In the present investigation the effect of pentoxifylline on single red cell deformability was determined. The deformability of human red blood cells were measured in a Singlepore Erythrocytes Rigidometer (SER). The new method determines optoelectronically the passage of each individual cell through a singlepore membrane (6 micrometers diameter and 50 micrometers length) under a driving pressure gradient (delta p = 100 Pa, tau = 3 Pa). Venous human blood samples were taken, prepared and divided into three samples. Sample A served as a physiological control, while to sample B and C CaCl2-solution was added. After Ca2+ stress sample C was incubated with 0.36 mmol/l pentoxifylline. The medium passage time (MPT) for sample A was 43.3 +/- 6.5 ms and for sample B 87.5 +/- 14.7 ms. The addition of pentoxifylline to the Ca2+-treated red cell suspension (sample C) reduced the MPT to 51.6 +/- 11.3 ms.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7311396     DOI: 10.1007/bf01747760

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  8 in total

1.  [Measurement of the erythrocyte deformability influenced by pentoxifyllin and lowmolecular dextran].

Authors:  U Werner
Journal:  Med Welt       Date:  1975-11-14

2.  Effects of pentoxifylline on red blood cell deformability and blood viscosity under hyperosmolar conditions.

Authors:  H Leonhardt; H G Grigoleit
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-09       Impact factor: 3.000

3.  Rheological changes in the blood of patients with chronic arterial occlusive disease after the administration of vasoactive drugs.

Authors:  B Störmer; K Kleinschmidt; D Loose; K Kremer
Journal:  Curr Med Res Opin       Date:  1977       Impact factor: 2.580

4.  The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.

Authors:  A M Ehrly
Journal:  J Med       Date:  1979

5.  [Drug-induced improvement of blood flow properties. Effective principle in the treatment of arterial occlusive diseases].

Authors:  H Hess; I Franke; M Jauch
Journal:  Fortschr Med       Date:  1973-06-14

6.  Amelioration of blood viscosity in sickle cell anemia by pentoxifylline. A case report.

Authors:  F Keller; H Leonhardt
Journal:  J Med       Date:  1979

7.  Studies on vasoocclusive crisis of sickle cell disease. I. Effect of pentoxifylline.

Authors:  J L Ambrus; C M Ambrus; H Gastpar; R Bannerman; R Bettigole; S Friedman
Journal:  J Med       Date:  1979

8.  Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease.

Authors:  B Angelkort; N Maurin; K Boateng
Journal:  Curr Med Res Opin       Date:  1979       Impact factor: 2.580

  8 in total
  3 in total

1.  Correction by pentoxifylline of the abnormal fluorescence polarization of erythrocyte membranes from diabetic patients.

Authors:  D Rahmani-Jourdheuil; I Juhan-Vague; C Roul; Y Mourayre; Z Mishal; J le Petit; P Vague
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  24-h blood glucose pattern in type I and type II diabetics after oral treatment with pentoxifylline as assessed by artificial endocrine pancreas.

Authors:  S Raptis; A Mitrakou; D Hadjidakis; E Diamantopoulos; C Anastasiou; A Fountas; R Müller
Journal:  Acta Diabetol Lat       Date:  1987 Jul-Sep

Review 3.  Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy.

Authors:  A Ward; S P Clissold
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.